Monte Rosa Therapeutics · 1 day ago
Director, New Product Planning
US-MA-Boston
Full-time
Onsite
Director/Executive
9+ years expMonte Rosa Therapeutics is focused on shaping the commercial success of its emerging pipeline. The Director of Commercial and Market Access Planning will lead global commercial assessments and develop go-to-market strategies for new therapeutic candidates, ensuring optimal pricing and reimbursement potential.
BiotechnologyMedicalTherapeutics
Responsibilities
Direct commercial planning for pipeline assets, with a focus on our clinical-stage programs
Design, direct, and implement global primary and secondary market research plans (qualitative and quantitative) to uncover stakeholder insights (physicians, patients, payers) to inform target product profiles, positioning, and forecasting assumptions
Develop detailed product revenue forecasts using robust methodologies and scenario modeling, assessing market opportunities, competitive dynamics, and patient populations
Develop early global pricing and market access strategies to inform target product profiles (TPP), ensuring clinical trial endpoints support future payer value propositions
Lead payer landscape assessments across key markets (US, EU5, Asia) to identify reimbursement hurdles, evidence gaps, and pricing sensitivity
Monitor the evolving policy landscape (e.g., Inflation Reduction Act, HTA reforms) to anticipate risks to pricing and access, adjusting commercial strategies accordingly
Define value drivers and evidence generation plans that resonate with payers and health technology assessment (HTA) bodies
Support launch readiness assessment and planning
Partner with R&D, clinical, regulatory, business development, and finance teams to integrate commercial perspectives into pipeline strategy
Translate complex market insights into clear strategic recommendations for executive leadership; present strategic recommendations and forecasts to senior leadership and key stakeholders
Utilize AI-enabled tools and analytics tools to streamline research, forecasting, and data synthesis
Support business development activities through assessment of in-licensing and partnership opportunities
Manage external vendors, consultants, and research partners as needed
Qualification
Required
BS with 14+ years of working experience, MS with 12+ years of experience, or Doctorate Degree with 9+ years of experience
8+ years of experience in commercial planning, new product planning, or related strategic roles within biotechnology/pharmaceutical companies and consulting
Proven track record directing and implementing market research programs for early- and late-stage assets
Hands-on experience designing and executing market research (not just managing vendors) and translating insights into actionable strategy
Demonstrated expertise developing detailed financial forecasts and market opportunity assessments
Proven ability to build complex, patient-based revenue forecast models from scratch in Excel
Strong knowledge of payer landscape, policy trends, and pricing frameworks
Deep understanding of syndicated data sets from IQVIA and other vendors
Deep experience developing and pressure-testing Target Product Profiles (TPPs), translating market insights into product requirements
Demonstrated experience developing global pricing strategies, payer value propositions, and reimbursement roadmaps for pipeline assets
Demonstrated familiarity with AI tools for market analysis, competitive intelligence, and workflow efficiency
Preferred
MBA, PhD, MD, PharmD, or MPH strongly preferred
Strong preference for candidates that have led commercial planning for Phase 2 and 3 programs at a biopharmaceutical company (or companies)
Additional experience at a consulting firm specializing in life sciences strategy, forecasting, or market analytics is a plus
Therapeutic Area: Experience in immunology, oncology and cardiovascular diseases is preferred
Company
Monte Rosa Therapeutics
Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.
51-200 employees
H1B Sponsorship
Monte Rosa Therapeutics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2024 (1)
2022 (4)
2020 (1)
Funding
Current Stage
Public CompanyTotal Funding
$648.5MKey Investors
Avoro Capital AdvisorsAisling Capital
2026-01-08Post Ipo Equity· $300M
2024-05-15Post Ipo Equity· $100M
2023-10-26Post Ipo Equity· $25M
Leadership Team
S
Sharon Townson
Chief Scientific Officer
Recent News
2026-01-11
2026-01-09
BioWorld Financial Watch
2026-01-09
Company data provided by crunchbase